Related Experiment Video
Updated: Jul 24, 2026
07:09
The Sciatic Nerve Cuffing Model of Neuropathic Pain in Mice
Published on: July 16, 2014
[Curative effect of gabapentin on refractory epilepsy]
Guo-Xing Zhu1, Mei-Ping Ding, Bo Xiao
1Institute of Neurology, Huashan Hospital, Fudan University, Shanghai 200040.
Zhonghua Yi Xue Za Zhi
|March 19, 2005
Summary
Gabapentin effectively reduces seizure frequency in patients with refractory epilepsy, showing significant improvements in seizure control and cognitive function without serious side effects.
Area of Science:
- Neurology
- Clinical Pharmacology
Background:
- Refractory epilepsy presents a significant challenge in patient management.
- Exploring novel therapeutic agents is crucial for improving seizure control.
Purpose of the Study:
- To evaluate the safety and efficacy of gabapentin in treating patients with refractory epilepsy.
- To assess the impact of gabapentin on seizure frequency, cognitive function, and daily living activities.
Main Methods:
- A double-blind study involving 138 patients with refractory epilepsy across five Chinese hospitals.
- Patients received either gabapentin (200 mg/d) or a placebo, with assessments every four weeks.
- Seizure frequency, Mini-Mental State Examination (MMSE), and Activities of Daily Life (ADL) were monitored.
Main Results:
- Gabapentin significantly reduced seizure times compared to placebo, particularly at weeks 12 and 20.
- Higher efficacy rates (>75% seizure reduction) were observed in the gabapentin group at multiple time points.
- Significant improvements in MMSE scores were noted in the gabapentin group at 16 weeks, with no significant changes in ADL.
- No serious adverse events were reported in either group.
Conclusions:
- Gabapentin, at a dosage of 1200 mg/d, is a safe and effective treatment option for refractory epilepsy.
- The study supports gabapentin's role in improving seizure control and cognitive function in this patient population.
More Related Videos
Related Concept Videos
01:24Epilepsy and Seizures: Overview
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
01:08Antiepileptic Drugs: Sodium Channel Blockers
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
01:18Antiepileptic Drugs: GABAergic Pathway Potentiators
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for their...
01:14Antiepileptic Drugs: Glutamate Antagonists
Glutamate is a fundamental neurotransmitter in the central nervous system, playing a vital role in neuronal communication and various cognitive processes. Glutamate stands as the principal excitatory neurotransmitter in the brain. Its presence is crucial for the communication between neurons, underpinning essential processes such as synaptic transmission, neuronal excitability, and plasticity. These functions are vital for higher-order cognitive processes, including learning and memory. The...
01:20Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
01:20Antiepileptic Drugs: Potassium Channel Activators
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
Ezogabine has gained approval as an adjunctive treatment...